We are testing IAM1363 in patients with HER2-positive cancers to see how safe it is and to find the right dosage. This study aims to gather important information for future treatments.
Health conditions and diseases that the clinical trial is designed to study and treat.
HER2 gene amplification refers to an increase in the number of copies of the HER2 gene, which can lead to aggressive growth of certain types of cancer, particularly breast cancer. This condition is often targeted in specific cancer treatments.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
